Brain Advance Access published online on November 7, 2003
Brain, doi:10.1093/brain/awh029
© 2003 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review Article
1 Division of Neurosurgery, Toronto Western Hospital, Toronto Western Research Institute, Ontario, Canada
* Corresponding author. E-mail: lozano{at}uhnres.utoronto.ca or c.hamani@sympatico.ca.
Received 18 June 2003
; revised 3 September 2003
; accepted 8 September 2003
The subthalamic nucleus (STN) has been regarded as an important modulator of basal ganglia output. It receives its major afferents from the cerebral cortex, thalamus, globus pallidus externus and brainstem, and projects mainly to both segments of the globus pallidus, substantia nigra, striatum and brainstem. The STN is essentially composed of projection glutamatergic neurons. Lesions of the STN induce choreiform abnormal movements and ballism on the contralateral side of the body. In animal models of Parkinson’s disease this nucleus may be dysfunctional and neurons may fire in oscillatory patterns that can be closely related to tremor. Both STN lesions and high frequency stimulation ameliorate the major motor symptoms of parkinsonism in humans and animal models of Parkinson’s disease and reverse certain electrophysiological and metabolic consequences of dopamine depletion. These new findings have led to a renewed interest in the STN. The aim of the present article is to review briefly the major anatomical, pharmacological and physiological aspects of the STN, as well as its involvement in the pathophysiology and treatment of Parkinson’s disease.
Keywords: subthalamic nucleus; Parkinson’s disease; basal ganglia; deep brain stimulation; movement disorders
The subthalamic nucleus in the context of movement disorders
2 Department of Neurological Surgery, Weill Medical College of Cornell University and Division of Neurosurgery, Memorial-Sloan Kettering Cancer Center, New York, NY, USA
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Mukhida, M. Hong, G.B. Miles, T. Phillips, B.A. Baghbaderani, M. McLeod, N. Kobayashi, A. Sen, L.A. Behie, R.M. Brownstone, et al. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats Brain, August 1, 2008; 131(8): 2106 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Strauss, F.-W. Zhou, J. Henning, A. Battefeld, A. Wree, R. Kohling, S. J.-P. Haas, R. Benecke, A. Rolfs, and U. Gimsa Increasing Extracellular Potassium Results in Subthalamic Neuron Activity Resembling That Seen in a 6-Hydroxydopamine Lesion J Neurophysiol, June 1, 2008; 99(6): 2902 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Lin, M. Carbon, C. Tang, A. Y. Mogilner, D. Sterio, A. Beric, V. Dhawan, and D. Eidelberg Metabolic correlates of subthalamic nucleus activity in Parkinson's disease Brain, May 1, 2008; 131(5): 1373 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Feigin, M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan, M. J. During, and D. Eidelberg Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease PNAS, December 4, 2007; 104(49): 19559 - 19564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Li, G. W. Arbuthnott, M. J. Jutras, J. A. Goldberg, and D. Jaeger Resonant Antidromic Cortical Circuit Activation as a Consequence of High-Frequency Subthalamic Deep-Brain Stimulation J Neurophysiol, December 1, 2007; 98(6): 3525 - 3537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg Changes in network activity with the progression of Parkinson's disease Brain, July 1, 2007; 130(7): 1834 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Castner, H. J. Chenery, D. A. Copland, T. J. Coyne, F. Sinclair, and P. A. Silburn Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease Brain, May 1, 2007; 130(5): 1395 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Asanuma, C. Tang, Y. Ma, V. Dhawan, P. Mattis, C. Edwards, M. G. Kaplitt, A. Feigin, and D. Eidelberg Network modulation in the treatment of Parkinson's disease Brain, October 1, 2006; 129(10): 2667 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Neimat, P. G. Patil, and A. M. Lozano Novel Surgical Therapies for Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 715 - 718. [Abstract] [PDF]
|
|
|
|
|
|
J. I. Kass and I. M. Mintz Silent plateau potentials, rhythmic bursts, and pacemaker firing: Three patterns of activity that coexist in quadristable subthalamic neurons PNAS, January 3, 2006; 103(1): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Foffani, A. M Bianchi, G Baselli, and A Priori Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus J. Physiol., October 15, 2005; 568(2): 699 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Maschke, P J Tuite, K Pickett, T Wachter, and J Konczak The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 569 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hanajima, P. Ashby, A. M. Lozano, A. E. Lang, and R. Chen Single Pulse Stimulation of the Human Subthalamic Nucleus Facilitates the Motor Cortex at Short Intervals J Neurophysiol, September 1, 2004; 92(3): 1937 - 1943. [Abstract] [Full Text] [PDF]
|
|